🔎 Trials Near Me

Home › Alzheimer's Disease › New Jersey › Toms River

Alzheimer's Disease clinical trials in Toms River, NJ

9 studies for Alzheimer's Disease are looking for participants at sites in and around Toms River (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

RecruitingPhase 2
  • Bio Behavioral Health, Toms River
Ages 55 and older · All sexes · Updated Sep 29, 2026 · NCT06540833

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

RecruitingPhase 3
  • Advanced Memory Research Institute - CenExel - PPDS, Toms River
Ages 55 to 90 · All sexes · Updated Sep 22, 2026 · NCT06585787

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

RecruitingPhase 2
  • CenExel Research - Toms River, Toms River
Ages 55 to 80 · All sexes · Updated Sep 21, 2026 · NCT06847321

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

RecruitingPhase 3
  • Local Institution - 2650, Toms River
Ages 55 to 90 · All sexes · Updated Sep 16, 2026 · NCT07011745

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

RecruitingPhase 2
  • Local Institution - 0081, Toms River
Ages 55 to 90 · All sexes · Updated Sep 1, 2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

RecruitingPhase 2
  • CenExel- AMRI ( Site 1018), Toms River
Ages 50 to 85 · All sexes · Updated Aug 26, 2026 · NCT07033494

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

RecruitingPhase 1
  • CenExel AMRI, Toms River
Ages 50 to 85 · All sexes · Updated Aug 24, 2026 · NCT06297590

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

RecruitingPhase 3
  • Advanced Memory Research Institute of New Jersey, Toms River
Ages 60 to 85 · All sexes · Updated Aug 20, 2026 · NCT06976216

Open-label Extension Study in Participants With Early Alzheimer's Disease

RecruitingPhase 2
  • GSK Investigational Site, Toms River
Ages 50 to 85 · All sexes · Updated Feb 2, 2026 · NCT07105709

About Alzheimer's Disease

Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.

More about Alzheimer's Disease on MedlinePlus

Alzheimer's Disease trials in other cities

Other studies in Toms River

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.